Vistagen Therapeutics, Inc. - COMM (VTGN)

Historical Portfolio Holders from Q2 2016 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COMM
Shares, excl. options Q2 2024
2.68M
Holdings value Q2 2024
$9.31M
Value change Q2 2024
$0
Grand Portfolio weight change Q2 2024
0%
Number of holders
1
Number of buys Q2 2024
0
Number of sells Q2 2024
0
Average buys Q2 2024 %
0
Average sells Q2 2024 %
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 2.68M $9.31M $0 $3.48 1
2024 Q1 2.68M $14.1M $0 $5.28 1
2023 Q4 2.68M $13.8M +$13.8M $5.14 1
2023 Q3 0 $0 -$9.16K 0
2023 Q2 4.9K $9.16K -$4.94M $1.87 1
2023 Q1 38.4M $4.79M -$217K $0.12 80
2022 Q4 40.2M $4.14M -$2.12M $0.10 78
2022 Q3 55.6M $8.46M -$76.1M $0.15 80
2022 Q2 139M $122M +$483K $0.88 106
2022 Q1 135M $168M -$4.88M $1.24 113
2021 Q4 138M $268M +$10.2M $1.95 102
2021 Q3 131M $360M +$21.4M $2.74 99
2021 Q2 123M $389M +$60.6M $3.15 99
2021 Q1 106M $225M +$83M $2.13 69
2020 Q4 67.3M $131M +$118M $1.94 50
2020 Q3 3.39M $2.36M +$679K $0.70 25
2020 Q2 2.44M $1.28M +$97.4K $0.52 22
2020 Q1 2.23M $982K -$187K $0.44 18
2019 Q4 2.49M $1.72M -$887K $0.69 23
2019 Q3 3.78M $4.05M +$1.01M $1.07 22
2019 Q2 3.2M $2.32M -$3.25M $0.73 20
2019 Q1 6.23M $7.97M +$3.93M $1.28 24
2018 Q4 3.12M $4.68M +$718K $1.50 20
2018 Q3 2.62M $3.8M +$311K $1.45 16
2018 Q2 2.28M $3.12M +$390K $1.37 18
2018 Q1 2.17M $2.02M -$2.55M $0.93 18
2017 Q4 4.71M $5.23M +$3.27M $1.11 13
2017 Q3 1.74M $2.79M +$806K $1.60 12
2017 Q2 1.23M $2.3M -$256K $1.86 13
2017 Q1 1.37M $2.68M -$1.24M $1.96 11
2016 Q4 1.68M $6.27M -$374K $3.73 12
2016 Q3 1.78M $7.45M +$19K $4.17 12
2016 Q2 1.78M $6.94M +$6.94M $3.90 10